Neogen Other Stockholder Equity vs Inventory Analysis
| NEOG Stock | USD 13.54 0.13 0.97% |
Neogen financial indicator trend analysis is infinitely more than just investigating Neogen recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neogen is a good investment. Please check the relationship between Neogen Other Stockholder Equity and its Inventory accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
Other Stockholder Equity vs Inventory
Other Stockholder Equity vs Inventory Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neogen Other Stockholder Equity account and Inventory. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Neogen's Other Stockholder Equity and Inventory is 0.81. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Inventory in the same time period over historical financial statements of Neogen, assuming nothing else is changed. The correlation between historical values of Neogen's Other Stockholder Equity and Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Neogen are associated (or correlated) with its Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory has no effect on the direction of Other Stockholder Equity i.e., Neogen's Other Stockholder Equity and Inventory go up and down completely randomly.
Correlation Coefficient | 0.81 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Other Stockholder Equity
Inventory
Most indicators from Neogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.At this time, Neogen's Enterprise Value Multiple is most likely to increase significantly in the upcoming years. The Neogen's current Enterprise Value is estimated to increase to about 3.8 B, while Tax Provision is projected to decrease to roughly 707.9 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 243.0M | 406.0M | 466.8M | 490.2M | Total Revenue | 527.2M | 822.4M | 945.8M | 993.1M |
Neogen fundamental ratios Correlations
Click cells to compare fundamentals
Neogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neogen fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
| Other Current Liab | 22.8M | 25.0M | 36.3M | 60.9M | 70.0M | 73.5M | |
| Total Current Liabilities | 48.5M | 53.6M | 77.8M | 145.5M | 167.3M | 175.7M | |
| Total Stockholder Equity | 725.2M | 840.4M | 887.4M | 3.1B | 3.6B | 3.8B | |
| Property Plant And Equipment Net | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
| Net Debt | (342.6M) | (379.8M) | 605.6M | 736.8M | 663.1M | 696.2M | |
| Retained Earnings | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 682.3M | |
| Cash | 343.7M | 381.1M | 381.1M | 163.2M | 187.7M | 197.1M | |
| Non Current Assets Total | 259.8M | 328.7M | 366.1M | 4.0B | 4.6B | 4.8B | |
| Non Currrent Assets Other | 2.2M | 2.0M | 2.2M | 15.2M | 17.5M | 15.5M | |
| Cash And Short Term Investments | 343.7M | 381.1M | 381.1M | 245.6M | 282.4M | 296.5M | |
| Net Receivables | 84.7M | 91.8M | 99.7M | 153.3M | 176.2M | 185.1M | |
| Common Stock Shares Outstanding | 105.7M | 107.1M | 108.0M | 188.9M | 217.2M | 228.1M | |
| Liabilities And Stockholders Equity | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
| Non Current Liabilities Total | 23.5M | 26.2M | 27.7M | 1.3B | 1.5B | 1.5B | |
| Inventory | 95.1M | 100.7M | 122.3M | 133.8M | 153.9M | 161.6M | |
| Other Current Assets | 14.0M | 17.8M | 23.8M | 53.3M | 61.3M | 64.4M | |
| Other Stockholder Equity | 257.7M | 295.0M | 310.0M | 2.6B | 3.0B | 3.1B | |
| Total Liab | 72.0M | 79.8M | 105.6M | 1.4B | 1.6B | 1.7B | |
| Property Plant And Equipment Gross | 80.6M | 102.9M | 215.5M | 318.9M | 366.7M | 385.0M | |
| Total Current Assets | 537.4M | 591.5M | 626.8M | 585.9M | 673.8M | 707.5M | |
| Accumulated Other Comprehensive Income | (19.7M) | (11.4M) | (27.8M) | (33.3M) | (29.9M) | (28.4M) | |
| Intangible Assets | 66.6M | 92.3M | 107.5M | 1.6B | 1.8B | 1.9B | |
| Accounts Payable | 25.7M | 23.9M | 34.6M | 76.7M | 88.2M | 92.6M | |
| Common Stock Total Equity | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 41.8M | |
| Short Term Investments | 277.4M | 305.5M | 336.6M | 82.3M | 94.7M | 91.9M | |
| Common Stock | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 37.8M | |
| Other Liab | 22.6M | 26.2M | 27.7M | 375.7M | 432.1M | 453.7M | |
| Other Assets | 2.2M | 2.0M | 4.8B | 15.2M | 17.5M | 16.6M | |
| Good Will | 181.1M | 228.3M | 255.5M | 3.8B | 4.3B | 4.6B | |
| Property Plant Equipment | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
| Net Tangible Assets | 599.6M | 612.1M | 887.4M | 3.1B | 3.6B | 3.8B | |
| Retained Earnings Total Equity | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 382.8M |
Currently Active Assets on Macroaxis
When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Neogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share 0.02 | Revenue Per Share 4.293 | Quarterly Revenue Growth 0.048 | Return On Assets 0.0179 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.